AKR1B1 and Hepatic fibrosis: Interestingly, it has been reported that the aldose reductase inhibitor (Z)2-(5-(4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl)acetic acid protected rats against CCl4-induced hepatic fibrosis.